A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide
Authors
Keywords
-
Journal
Nature Communications
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-09-13
DOI
10.1038/s41467-017-00721-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Bioengineered Three-Dimensional Cell Culture Platform Integrated with Microfluidics To Address Antimicrobial Resistance in Tuberculosis
- (2017) Magdalena K. Bielecka et al. mBio
- Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis
- (2016) Gustavo E. Velásquez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular principles behind pyrazinamide resistance due to mutations in panD gene in Mycobacterium tuberculosis
- (2016) Bharati Pandey et al. GENE
- Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project
- (2016) Matteo Zignol et al. LANCET INFECTIOUS DISEASES
- A quantitative adaptation of the Wayne test for pyrazinamide resistance
- (2016) Christopher Meinzen et al. TUBERCULOSIS
- Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline
- (2015) Andreas H. Diacon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Systematic Review of Mutations in Pyrazinamidase Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis Clinical Isolates
- (2015) Sarah M. Ramirez-Busby et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Uncoupling Environmental pH and Intrabacterial Acidification from Pyrazinamide Susceptibility in Mycobacterium tuberculosis
- (2015) Nicholas D. Peterson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mycobacterium tuberculosispncAPolymorphisms That Do Not Confer Pyrazinamide Resistance at a Breakpoint Concentration of 100 Micrograms per Milliliter in MGIT: TABLE 1
- (2015) Michael G. Whitfield et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis
- (2015) Rodney Dawson et al. LANCET
- Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study
- (2015) Timothy M Walker et al. LANCET INFECTIOUS DISEASES
- Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives
- (2015) Laura E. Via et al. ACS Infectious Diseases
- A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis
- (2015) Michael G. Whitfield et al. PLoS One
- New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
- (2014) Alimuddin I Zumla et al. LANCET INFECTIOUS DISEASES
- Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study
- (2014) P. Miotto et al. mBio
- Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience
- (2013) S. Hoffner et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Role of pncA and rpsA Gene Sequencing in Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates from Southern China
- (2013) Y. Tan et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis
- (2013) Shuo Zhang et al. Emerging Microbes & Infections
- Systematic Analysis of Pyrazinamide-Resistant Spontaneous Mutants and Clinical Isolates of Mycobacterium tuberculosis
- (2012) Karolien Stoffels et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pyrazinamide May Improve Fluoroquinolone-Based Treatment of Multidrug-Resistant Tuberculosis
- (2012) Kwok-Chiu Chang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Gene Sequencing for Routine Verification of Pyrazinamide Resistance in Mycobacterium tuberculosis: a Role for pncA but Not rpsA
- (2012) D. C. Alexander et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Role ofrpsAGene Sequencing in Diagnosis of Pyrazinamide Resistance: Table 1
- (2012) Sami O. Simons et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide
- (2012) J. Grosset et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Correction: Slit2/Robo4 Signaling Modulates HIV-1 gp120-Induced Lymphatic Hyperpermeability
- (2012) Xuefeng Zhang et al. PLoS Pathogens
- Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: a Systematic Review with Meta-Analyses
- (2011) Kwok Chiu Chang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Validation of pncA Gene Sequencing in Combination with the Mycobacterial Growth Indicator Tube Method To Test Susceptibility of Mycobacterium tuberculosis to Pyrazinamide
- (2011) S. O. Simons et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to Pyrazinamide
- (2011) Stéphanie Petrella et al. PLoS One
- Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
- (2011) W. Shi et al. SCIENCE
- Fast and accurate predictions of protein stability changes upon mutations using statistical potentials and neural networks: PoPMuSiC-2.0
- (2009) Yves Dehouck et al. BIOINFORMATICS
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- Potential for Erroneous Results Indicating Resistance When Using the Bactec MGIT 960 System for Testing Susceptibility ofMycobacterium tuberculosisto Pyrazinamide
- (2009) Pamela Chedore et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Characterisation of pncA mutations in clinical Mycobacterium tuberculosis isolates in New Zealand
- (2009) Sushil Pandey et al. PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search